Literature DB >> 26016582

Can pharmacologic agents speed the rate of resorption of pleural fluid?

Sotirios G Zarogiannis1, Ioannis Kalomenidis.   

Abstract

PURPOSE OF REVIEW: Pleural effusion is a common clinical problem resulting from a wide range of diseases. Treatment options include targeting the primary cause or, in persistent cases, invasive removal of the excess fluid from the pleural cavity. In this review, we summarize the experimental data concerning pharmacological agents that influence pleural fluid resorption and examine their potential as a novel noninvasive treatment strategy. RECENT
FINDINGS: Recently published evidence indicates that adrenergic agents and corticosteroids can increase pleural fluid clearance from the cavity. On the contrary, paracetamol and certain nonsteroid anti-inflammatory drugs can impede fluid outflow. These concepts are based on data extracted by in-vivo studies using provoked hydrothoraces in rabbits and mice, as well as by ex-vivo electrophysiological experiments using sheep and human pleural tissue.
SUMMARY: In conclusion, the available experimental data indicate that certain pharmacological agents may impact fluid resorption, thus affecting pleural fluid accumulation and the rate of pleural effusion resolution.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26016582     DOI: 10.1097/MCP.0000000000000170

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  2 in total

1.  Folliculin haploinsufficiency causes cellular dysfunction of pleural mesothelial cells.

Authors:  Shouichi Okamoto; Hiroki Ebana; Masatoshi Kurihara; Keiko Mitani; Etsuko Kobayashi; Takuo Hayashi; Yasuhito Sekimoto; Koichi Nishino; Mizuto Otsuji; Toshio Kumasaka; Kazuhisa Takahashi; Kuniaki Seyama
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

2.  Editorial: Mesothelial Physiology and Pathophysiology.

Authors:  Sotirios G Zarogiannis
Journal:  Front Physiol       Date:  2018-03-22       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.